These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
521 related items for PubMed ID: 1627245
1. Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporin nephrotoxicity. Yilmaz S, Taskinen E, Paavonen T, Mennander A, Häyry P. Transpl Int; 1992 May; 5(2):85-95. PubMed ID: 1627245 [Abstract] [Full Text] [Related]
2. Evolution of glomerular basement membrane changes in chronic rejection. Yilmaz A, Yilmaz S, Kallio E, Rapola J, Häyry P. Transplantation; 1995 Dec 15; 60(11):1314-22. PubMed ID: 8525527 [Abstract] [Full Text] [Related]
3. Chronic rejection of rat renal allograft. III. Ultrastructure of vascular and glomerular changes. Yilmaz A, Yilmaz S, Paavonen T, Rapola J, Häyry P. Int J Exp Pathol; 1992 Jun 15; 73(3):371-85. PubMed ID: 1622847 [Abstract] [Full Text] [Related]
4. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Yilmaz S, Koskinen PK, Kallio E, Bruggeman CA, Häyry PJ, Lemström KB. Kidney Int; 1996 Aug 15; 50(2):526-37. PubMed ID: 8840282 [Abstract] [Full Text] [Related]
5. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. de Heer E, Davidoff A, van der Wal A, van Geest M, Paul LC. Lab Invest; 1994 Apr 15; 70(4):494-502. PubMed ID: 8176888 [Abstract] [Full Text] [Related]
6. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker. Osterholm C, Veress B, Simanaitis M, Hedner U, Ekberg H. Transpl Immunol; 2005 Dec 15; 15(2):165-72. PubMed ID: 16412961 [Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection. Rintala SE, Savikko J, Rintala JM, von Willebrand E. Transplant Proc; 2006 Dec 15; 38(10):3236-8. PubMed ID: 17175233 [Abstract] [Full Text] [Related]
8. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Heemann UW, Azuma H, Tullius SG, Mackenzie H, Brenner BM, Tilney NL. Transplantation; 1994 Dec 27; 58(12):1317-22. PubMed ID: 7528948 [Abstract] [Full Text] [Related]
9. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity. Fuggle SV, McWhinnie DL, Morris PJ. Transpl Int; 1989 Oct 27; 2(3):123-8. PubMed ID: 2679626 [Abstract] [Full Text] [Related]
10. Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Yilmaz S, Paavonen T, Häyry P. Transplantation; 1992 Apr 27; 53(4):823-7. PubMed ID: 1566348 [Abstract] [Full Text] [Related]
11. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts. Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K. Nephrol Dial Transplant; 2006 May 27; 21(5):1365-72. PubMed ID: 16449275 [Abstract] [Full Text] [Related]
12. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression. Rintala JM, Savikko J, Rintala SE, von Willebrand E. Transplant Proc; 2006 Dec 27; 38(10):3239-40. PubMed ID: 17175234 [Abstract] [Full Text] [Related]
13. Protective effects of atorvastatin on chronic allograft nephropathy in rats. Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M. J Surg Res; 2007 Dec 27; 143(2):428-36. PubMed ID: 17628598 [Abstract] [Full Text] [Related]
14. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy. Savikko J, Taskinen E, Von Willebrand E. Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194 [Abstract] [Full Text] [Related]
15. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts. Rintala JM, Savikko J, Rintala SE, von Willebrand E. Nephrol Dial Transplant; 2008 Nov 27; 23(11):3446-55. PubMed ID: 18558624 [Abstract] [Full Text] [Related]
17. Rat cytomegalovirus infection and chronic kidney allograft rejection. Koskinen PK, Yilmaz S, Kallio E, Bruggeman CA, Häyry PJ, Lemström K. Transpl Int; 1996 Nov 27; 9 Suppl 1():S3-4. PubMed ID: 8959777 [Abstract] [Full Text] [Related]
18. Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Tullius SG, Hancock WW, Heemann U, Azuma H, Tilney NL. Transplantation; 1994 Jul 15; 58(1):93-9. PubMed ID: 8036713 [Abstract] [Full Text] [Related]
19. Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts. Heemann UW, Azuma H, Tullius SG, Schmid C, Philipp T, Tilney NL. Clin Nephrol; 1996 Jul 15; 46(1):34-8. PubMed ID: 8832148 [Abstract] [Full Text] [Related]
20. Functional and histologic characteristics of chronic renal allograft rejection. Paul LC. Clin Transplant; 1994 Jun 15; 8(3 Pt 2):319-23. PubMed ID: 8061373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]